Adma Biologics, Inc. 13F holders
Of the 44 funds followed here, 10 reported a position in Adma Biologics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Capital Research Global Investors, 8.8 million shares worth $73.3 million, 0.0% of its reported book.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 8,756,374 | $73.3 million | 0.0% | -2,434,742 | trimmed | 30 June 2026 | 13F |
| Geode Capital Management | 6,059,984 | $50.7 million | 0.0% | +235,868 | added | 30 June 2026 | 13F |
| Duquesne Family Office | 2,784,110 | $23.3 million | 0.4% | +1,238,500 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 2,019,887 | $16.9 million | 0.0% | -72,246 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 1,620,271 | $13.6 million | 0.0% | -4,626,971 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 1,154,228 | $9.7 million | 0.0% | -2,280,221 | trimmed | 30 June 2026 | 13F |
| Renaissance Technologies | 652,530 | $5.5 million | 0.0% | -610,104 | trimmed | 30 June 2026 | 13F |
| Point72 Asset Management | 499,135 | $4.2 million | 0.0% | -2,810,522 | trimmed | 30 June 2026 | 13F |
| Bridgewater Associates | 401,059 | $3.4 million | 0.0% | -71,049 | trimmed | 30 June 2026 | 13F |
| FMR LLC | 389,516 | $3.3 million | 0.0% | +50,577 | added | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 7 August 2026 | 13G | State Street Corporation and 3 others | 17.1 million | 7.4% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 29 April 2026 | 13G | Vanguard Capital Management and 1 other | 12.1 million | 5.1% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 February 2026 | 13G/A | Invesco Ltd. and 1 other | 11.8 million | 5.0% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 967 on 3 September 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to ADMA by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.